Enanta stockholders approve all proposals at 2022 annual meeting

ENANTA PHARMACEUTICALS INC

Elected Mark Foletta (16,269,503 votes for) and Lesley Russell (16,081,968 votes for) as Class III directors.
Approved amendment to 2019 Equity Incentive Plan, increasing reserved shares by 1,050,000.
Advisory say-on-pay proposal passed with 16,369,060 votes for, 933,286 against.
Ratified PricewaterhouseCoopers LLP as independent auditor for fiscal 2022 with 18,378,176 votes for.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.